Published in Ann Oncol on May 01, 2004
Bcl-2 expression predicts radiotherapy failure in laryngeal cancer. Br J Cancer (2005) 0.97
Liriodenine induces the apoptosis of human laryngocarcinoma cells via the upregulation of p53 expression. Oncol Lett (2014) 0.86
The role of COX-2 in rectal cancer treated with preoperative radiotherapy. Virchows Arch (2008) 0.82
Cyclooxygenase-2 inhibitor and cisplatin combination as a radiosensitizer in the treatment of head and neck cancer patients. Ann Oncol (2004) 0.77
Expression of Cox-2 protein in radioresistant laryngeal cancer. Ann Oncol (2004) 0.75
The effect of cyclooxygenase-2 expression on tumor volume response in patients treated with radiotherapy for uterine cervical cancer. J Korean Med Sci (2009) 0.75
Molecular characteristics of residual cancer and stromal cells after chemoradiotherapy for gastric cancer: report of four cases. Clin Case Rep (2014) 0.75
Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancer. BMC Cancer (2016) 0.75
Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro. Proc Natl Acad Sci U S A (1987) 4.04
Genetic abnormalities during transition from Helicobacter-pylori-associated gastritis to low-grade MALToma. Lancet (1995) 2.21
Randomized phase II study of two gemcitabine schedules for patients with impaired performance status (Karnofsky performance status </= 70) and advanced non-small-cell lung cancer. J Clin Oncol (2005) 2.17
Competition mediated by parasites: biological and theoretical progress. Trends Ecol Evol (1998) 1.90
Killing of cutaneous microbial species by photodynamic therapy. Br J Dermatol (2001) 1.52
Frequency of replication errors in colorectal cancer and their association with family history. Gut (1998) 1.46
Assessment of microsatellite alterations in young patients with gastric adenocarcinoma. Cancer (1997) 1.45
Polyethylene particles stimulate monocyte chemotactic and activating factor production in synovial mononuclear cells in vivo. An immunohistochemical study in rabbits. Acta Orthop Scand (1995) 1.44
Intraluminal thrombus has a selective influence on matrix metalloproteinases and their inhibitors (tissue inhibitors of matrix metalloproteinases) in the wall of abdominal aortic aneurysms. Ann Vasc Surg (2012) 1.44
Biofilm formation by Helicobacter pylori. Lett Appl Microbiol (1999) 1.39
Drug metabolism in human liver in vitro: establishment of a human liver bank. Clin Pharmacol Ther (1980) 1.39
Availability of insulin pump therapy in clinical practice. Diabet Med (2012) 1.38
On the question of dose-dependent chloroquine elimination of a single oral dose. Clin Pharmacol Ther (1983) 1.34
Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer. Clin Cancer Res (1998) 1.29
Reduced uptake of ciprofloxacin in a resistant strain of Neisseria gonorrhoeae and transformation of resistance to other strains. J Antimicrob Chemother (1991) 1.25
Fast neutron treatment for squamous cell carcinoma. BMJ (1991) 1.22
The development and characterisation of porphyrin isothiocyanate-monoclonal antibody conjugates for photoimmunotherapy. Br J Cancer (2005) 1.22
Amino acid utilisation and deamination of glutamine and asparagine by Helicobacter pylori. J Med Microbiol (1997) 1.17
Resorption of hydroxyapatite and fluorapatite ceramic coatings on weight-bearing implants: a quantitative and morphological study in dogs. J Biomed Mater Res (1998) 1.11
What to do about halitosis. BMJ (1994) 1.11
Genetic changes in breast cancer detected by comparative genomic hybridisation. Int J Cancer (2000) 1.10
Electrochemically activated solutions: evidence for antimicrobial efficacy and applications in healthcare environments. Eur J Clin Microbiol Infect Dis (2011) 1.09
Antimicrobial photodynamic therapy: assessment of genotoxic effects on keratinocytes in vitro. Br J Dermatol (2003) 1.09
Phase II studies of BBR3464, a novel tri-nuclear platinum complex, in patients with gastric or gastro-oesophageal adenocarcinoma. Eur J Cancer (2004) 1.08
Purification of the E. coli ogt gene product to homogeneity and its rate of action on O6-methylguanine, O6-ethylguanine and O4-methylthymine in dodecadeoxyribonucleotides. Nucleic Acids Res (1989) 1.08
Recombinant human vascular endothelial growth factor enhances bone healing in an experimental nonunion model. J Bone Joint Surg Br (2005) 1.08
Analysis of cultivable Porphyromonas gingivalis with trypsin-like protease enzyme activity and serum antibodies in chronic adult periodontitis. Oral Dis (1995) 1.07
Effect of pentobarbital on the disposition of alprenolol. Clin Pharmacol Ther (1977) 1.06
Potential prognostic and therapeutic roles for cytokines in breast cancer (Review). Oncol Rep (2006) 1.04
Identification of germline missense mutations and rare allelic variants in the ATM gene in early-onset breast cancer. Genes Chromosomes Cancer (1999) 1.04
Heat shock proteins in vascular disease--a review. Eur J Vasc Endovasc Surg (2005) 1.03
Intraindividual variability in the relative systemic availability of cyclosporin after oral dosing. Eur J Clin Pharmacol (1988) 1.03
Expression of a human O6-alkylguanine-DNA-alkyltransferase cDNA in human cells and transgenic mice. Nucleic Acids Res (1990) 1.03
Sealing effect of hydroxyapatite coating on peri-implant migration of particles. An experimental study in dogs. J Bone Joint Surg Br (2001) 1.02
Radioresistance in carcinoma of the breast. Breast (2004) 1.00
Steady-state plasma concentrations of alprenolol in man. Eur J Clin Pharmacol (1974) 1.00
Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer. J Laryngol Otol (2006) 1.00
Isolation and cDNA cloning of a rat O6-alkylguanine-DNA-alkyltransferase gene, molecular analysis of expression in rat liver. Carcinogenesis (1991) 0.99
The role of microsatellite instability in gastric carcinoma. Gut (1998) 0.99
Karyotypic variation between independently cultured strains of the cell line MCF-7 identified by multicolour fluorescence in situ hybridization. Int J Oncol (2002) 0.99
Evaluation of the efficacy of electrochemically activated solutions against nosocomial pathogens and bacterial endospores. Lett Appl Microbiol (2009) 0.97
Bcl-2 expression predicts radiotherapy failure in laryngeal cancer. Br J Cancer (2005) 0.97
Oxidation of (R)- and (S)-propranolol in human and dog liver microsomes. Species differences in stereoselectivity. J Pharmacol Exp Ther (1982) 0.97
Chromosomal analysis of non-small-cell lung cancer by multicolour fluorescent in situ hybridisation. Br J Cancer (2004) 0.96
Isolation and partial characterization of murine O6-alkylguanine-DNA-alkyltransferase: comparative sequence and structural properties. Mol Carcinog (1992) 0.96
High-dose, double alkylating agent chemotherapy with DTIC, melphalan, or ifosfamide and marrow rescue for metastatic malignant melanoma. Cancer (1989) 0.96
In vitro reaction to orthopaedic biomaterials by macrophages and lymphocytes isolated from patients undergoing revision surgery. Biomaterials (2001) 0.96
A literature review of head and neck cancer patients information needs, experiences and views regarding decision-making. Eur J Cancer Care (Engl) (2004) 0.96
Breath odor: etiopathogenesis, assessment and management. Eur J Oral Sci (1997) 0.95
Advanced colorectal cancer is associated with impaired interleukin 12 and enhanced interleukin 10 production. Clin Cancer Res (1998) 0.95
Prognostic value of genomic alterations in head and neck squamous cell carcinoma detected by comparative genomic hybridisation. Br J Cancer (2003) 0.94
Expression of the ogt gene in wild-type and ada mutants of E. coli. Nucleic Acids Res (1989) 0.94
Ifosfamide by continuous infusion to prevent encephalopathy. Lancet (1990) 0.94
Pre-operative serum vascular endothelial growth factor can select patients for adjuvant treatment after curative resection in colorectal cancer. Br J Cancer (2000) 0.93
Salivary-gland scanning with 99m technetium. Acta Otolaryngol (1969) 0.93
Epoetin alfa in platinum-treated ovarian cancer patients: results of a multinational, multicentre, randomised trial. Br J Cancer (2006) 0.93
Anti-p53 autoantibody in colorectal cancer: prognostic significance in long-term follow-up. Int J Colorectal Dis (2008) 0.93
First pass hydroxylation of nortriptyline: concentrations of parent drug and major metabolites in plasma. Eur J Clin Pharmacol (1977) 0.92
Halitosis management by the general dental practitioner--results of an international consensus workshop. J Breath Res (2014) 0.92
Use of a bioluminescent Pseudomonas aeruginosa strain within an in vitro microbiological system, as a model of wound infection, to assess the antimicrobial efficacy of wound dressings by monitoring light production. Antimicrob Agents Chemother (2007) 0.91
Increased nonrenal clearance and increased diuretic efficiency of furosemide in cystic fibrosis. Clin Pharmacol Ther (1988) 0.91
Recombinant human interleukin-4 (rhu IL-4) administered by the intravenous and subcutaneous routes in patients with advanced cancer--a phase I toxicity study and pharmacokinetic analysis. Eur J Cancer (1993) 0.91
Hydroxyapatite and fluorapatite coatings for fixation of weight loaded implants. Clin Orthop Relat Res (1997) 0.91
Vascular endothelial growth factor and psychosocial factors in colorectal cancer. Psychooncology (2008) 0.91
Demystified...recombinant antibodies. J Clin Pathol (2004) 0.91
Prognostic significance of microsatellite instability in patients with gastric carcinoma. Eur J Cancer (1997) 0.90
Tissue factor expression determines tumour cell coagulation kinetics. Int J Lab Hematol (2012) 0.89
Vascular endothelial growth factor in premenopausal women--indicator of the best time for breast cancer surgery? Br J Cancer (1998) 0.89
Carboplatin, ifosfamide and etoposide with mid-course vincristine and thoracic radiotherapy for 'limited' stage small cell carcinoma of the bronchus. Br J Cancer (1989) 0.89
Genetic changes associated with telomerase activity in breast cancer. Int J Cancer (1999) 0.89
In vitro, in vivo, and tissue retrieval studies on particulate debris. Clin Orthop Relat Res (1998) 0.89
Isolation and partial characterisation of a Chinese hamster O6-alkylguanine-DNA alkyltransferase cDNA. Nucleic Acids Res (1992) 0.89
Radioresistant laryngeal cancer: beyond the TNM stage. Clin Otolaryngol Allied Sci (2004) 0.89
Halitology (breath odour: aetiopathogenesis and management). Oral Dis (2012) 0.89
Th1/Th2 cytokine imbalance in meningioma, anaplastic astrocytoma and glioblastoma multiforme patients. Oncol Rep (2006) 0.88
Comparative pharmacokinetics of escalating doses of doxorubicin in patients with metastatic breast cancer. Cancer Chemother Pharmacol (1990) 0.88
Adult laryngeal rhabdomyosarcoma: report of a case and literature review. Ann Afr Med (2007) 0.88
Improved fixation of porous-coated versus grit-blasted surface texture of hydroxyapatite-coated implants in dogs. Acta Orthop Scand (1997) 0.88
Osteogenic protein-1 increases the fixation of implants grafted with morcellised bone allograft and ProOsteon bone substitute: an experimental study in dogs. J Bone Joint Surg Br (2007) 0.88
A phase II trial evaluating two schedules of sagopilone (ZK-EPO), a novel epothilone, in patients with platinum-resistant ovarian cancer. Ann Oncol (2011) 0.88
A review of ceramic coatings for implant fixation. J Long Term Eff Med Implants (1999) 0.88
Impaired interleukin-12 production is associated with a defective anti-tumor response in colorectal cancer. Dis Colon Rectum (1998) 0.88
Fibroblast expression of C-C chemokines in response to orthopaedic biomaterial particle challenge in vitro. J Orthop Res (2001) 0.87
Effect of local prostaglandin E2 on periosteum and muscle in rabbits. Acta Orthop Scand (1992) 0.86
Genetic analysis of head and neck squamous cell carcinoma and surrounding mucosa. Arch Otolaryngol Head Neck Surg (1999) 0.86
Proceedings: "First-pass" effect and dose dependent availability as factors contributing to interindividual differences in equilibrium concentrations of alprenolol in man. Acta Pharm Suec (1974) 0.86
Isolation of human colorectal tumour reactive antibodies using phage display technology. Int J Oncol (2000) 0.86
Serum-antibodies against the trypsin-like protease of Bacteroides gingivalis in periodontitis. J Periodontal Res (1988) 0.86
Importance of "first-pass elimination" for interindividual differences in steady-state concentrations of the adrenergic beta-receptor antagonist alprenolol. J Pharmacokinet Biopharm (1977) 0.86
Can a rational design for metronomic chemotherapy dosing be devised? Br J Cancer (2005) 0.86